Home / Blog / Obesity Research
2 articles
Retatrutide is an investigational triple-receptor agonist studied for weight loss, blood sugar, metabolic health, and ob…
New Phase 3 data from Eli Lilly shows retatrutide producing average weight loss of up to 28.3%, with some participants l…